-

Drug Analytical Method Validation, Verification and Transfer Virtual Seminar (Jan 14th - Jan 15th, 2026 and On-Demand) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Analytical Method Validation, Verification and Transfer Virtual Seminar (Jan 14th - Jan 15th, 2026)" training has been added to ResearchAndMarkets.com's offering.

Dependable analytical results are essential to making a knowledgeable choice about the excellence and care of the products in the medicinal business. Additionally, such investigative data is required for supervisory submissions in the provision of the drug creation recordings. Therefore, expressive untried projects including scheme appropriateness limits must be planned for the intended use of the process.

In this course, a general guideline for the determination of the analytical characteristics for different types of validation procedures is highlighted for the analysis of both the drug substance and drug product. The factors to consider for verification of the compendial procedures will also be discussed. In addition, different approaches for the transfer of analytical procedures from one lab (transferring) to another lab (s) (receiving) under different circumstances will be covered. Other related topics for obtaining reliable data will also be discussed. These topics include analytical instrument qualification as well as how to set, handle and monitor specifications.

In this Analytical Method Validation Training Course, the overall recommendation for the purpose of the logical features for diverse types of authentication measures is highlighted for the examination of the drug substance and drug product. The trainees will be required to pay attention to the influences to reflect for confirmation of the compendial actions that are an indivisible part of the training course.

In addition, different methods for the transmission of the analytical procedures from one lab (transferring) to another lab (s) (receiving) under different conditions will be enclosed. Other related topics for obtaining reliable data will also be discussed. These themes comprise logical tool requirements as well as how to set, grip and screen specifications.

Learning Objectives

The Analytical Method Validation Training Course follows a few objectives that every aspiring candidate needs to focus on while undergoing the course:

  • Drug Endorsement Process and Controlling Necessities (secluded values)
  • Substitute Official methods and options
  • Allowed Alterations of Chromatographic System Strictures
  • Pharmacopeias and Compendial Approval Process (public standards)
  • Logical Method Life Cycle
  • Investigative Method Authentication
  • Compendial Coordination Procedure
  • Analytical Instrument Qualifications including DQ, IQ, OQ, PQ
  • Analytical Method Verification
  • Analytical Method Transfer
  • Chromatography System Appropriateness Necessities
  • Analytical Method Validation
  • How to Set Specifications and how to handle out-of-specification (OOS) and out-of-trend (OOT) results

RAPS

This course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Who Should Attend:

Contract Laboratories (CRO), Academia (pharmacy, Pharmaceutical Industry, Pharmaceutical, Chemistry), government (FDA or regulatory authorities),

  • Quality Analysis Managers and Personnel
  • Controlling Personnel
  • Analytical and or Formulation Chemists
  • Quality Control Managers and Personnel
  • Lab Supervisors and Managers
  • Compendial Liaisons
  • Senior or Graduate students (chemistry, pharmaceutical, pharmacy)
  • Pharmaceutical scientists/Pharmacists working in Industry

Key Topics Covered:

  • Seminar objectives review, expectations, and scope.
  • Pharmacopoeias and Compendial (USP) Approval Process (public standards)
  • Analytical Method Validation (typical validation parameters)
  • Drug Approval Process and Regulatory (FDA) Requirements (private standards)
  • Chromatography System Suitability Requirements
  • Compendial Harmonization Process
  • Qualification Phases (DQ, IQ, OQ, PQ)
  • Precision/Accuracy
  • Allowed Adjustments of Chromatographic System Parameters
  • Specificity
  • Factors to Consider
  • LOD and LOQ
  • Analytical Method Verification
  • Analytical Instrument Qualifications
  • Analytical Method Transfer
  • Linearity/Range
  • FDA and USP Requirements
  • Instrument Categories
  • Different Approaches
  • Summary and Review
  • Investigative Procedure Life Cycle
  • Setting Stipulations FDA rules and ICH strategies (Q6A)
  • Out-of-Specification (OOS)
  • Out of Trend (OOT)
  • How to handle OOS and OOT?
  • Summary and Review

Speakers:

Kelly Thomas

Vice President

Stallergenes Greer

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.

Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.

For more information about this training visit https://www.researchandmarkets.com/r/j4b8ax

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Bangladesh Alternative Lending Databook Report 2025: Market Size & Forecast by Value and Volume Across 100+ KPIs 2020-2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bangladesh Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose, Finance Models, Distribution Channels, and Payment Instruments - Databook Q4 2025 Update" has been added to ResearchAndMarkets.com's offering. The alternative lending market in Bangladesh is showing significant potential for growth, with forecasts predicting a 13.2% annual increase, reaching US$1.83 billion by 2025. The...

Silicon Carbide (SiC) for Wireless EV Charging Market 2025-2034: Demand Forecast, Regional Insights, Company Profiles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Silicon Carbide (SiC) for Wireless EV Charging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The Global Silicon Carbide (SiC) for Wireless EV Charging Market was valued at USD 4.2 million in 2024 and is estimated to grow at a CAGR of 15.1% to reach USD 17 million by 2034. The surge in electric vehicle adoption worldwide is driving demand for SiC in wireless EV charging syste...

Belgium Alternative Lending Databook Report 2025: Market to Grow by 16.6% to Reach $4.26 Billion - Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Belgium Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose, Finance Models, Distribution Channels, and Payment Instruments - Databook Q4 2025 Update" report has been added to ResearchAndMarkets.com's offering. Alternative lending market in Belgium was expected to grow by 16.6% annually, reaching US$4.26 billion by 2025. The alternative lending market in the country has experienced...
Back to Newsroom